Abstract
Rapid decontamination of the skin is the single most important action to prevent dermal absorption of chemical contaminants in persons exposed to chemical warfare agents (CWA) and toxic industrial chemicals (TICs) as a result of accidental or intentional release. Chemicals on the skin may be removed by mechanical means through the use of dry sorbents or water. Recent interest in decontamination systems which both partition contaminants away from the skin and actively neutralize the chemical has led to the development of several reactive decontamination solutions. This article will review the recently FDA-approved Reactive Skin Decontamination Lotion (RSDL) and will summarize the toxicity and efficacy studies conducted to date. Evidence of RSDL’s superior performance against vesicant and organophosphorus chemical warfare agents compared to water, bleach, and dry sorbents, suggests that RSDL may have a role in mass human exposure chemical decontamination in both the military and civilian arenas.
Keywords: VX, soman, vesicants, sulfur mustard, dermal, decontamination, reactive skin decontamination lotion, chemical warfare, Rapid decontamination, chemical warfare agents (CWA), toxic industrial chemicals (TICs), decontamination systems, several reactive decontamination solutions, Reactive Skin Decontamination Lotion (RSDL), Evidence of RSDL’s.
Current Pharmaceutical Biotechnology
Title:Reactive Skin Decontamination Lotion (RSDL) for the Decontamination of Chemical Warfare Agent (CWA) Dermal Exposure
Volume: 13 Issue: 10
Author(s): M. D. Schwartz, C. G. Hurst, M. A. Kirk, S. J.D. Reedy and E. H. Braue
Affiliation:
Keywords: VX, soman, vesicants, sulfur mustard, dermal, decontamination, reactive skin decontamination lotion, chemical warfare, Rapid decontamination, chemical warfare agents (CWA), toxic industrial chemicals (TICs), decontamination systems, several reactive decontamination solutions, Reactive Skin Decontamination Lotion (RSDL), Evidence of RSDL’s.
Abstract: Rapid decontamination of the skin is the single most important action to prevent dermal absorption of chemical contaminants in persons exposed to chemical warfare agents (CWA) and toxic industrial chemicals (TICs) as a result of accidental or intentional release. Chemicals on the skin may be removed by mechanical means through the use of dry sorbents or water. Recent interest in decontamination systems which both partition contaminants away from the skin and actively neutralize the chemical has led to the development of several reactive decontamination solutions. This article will review the recently FDA-approved Reactive Skin Decontamination Lotion (RSDL) and will summarize the toxicity and efficacy studies conducted to date. Evidence of RSDL’s superior performance against vesicant and organophosphorus chemical warfare agents compared to water, bleach, and dry sorbents, suggests that RSDL may have a role in mass human exposure chemical decontamination in both the military and civilian arenas.
Export Options
About this article
Cite this article as:
D. Schwartz M., G. Hurst C., A. Kirk M., J.D. Reedy S. and H. Braue E., Reactive Skin Decontamination Lotion (RSDL) for the Decontamination of Chemical Warfare Agent (CWA) Dermal Exposure, Current Pharmaceutical Biotechnology 2012; 13 (10) . https://dx.doi.org/10.2174/138920112802273191
DOI https://dx.doi.org/10.2174/138920112802273191 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Potential Risks and Mitigation Strategies Before the Conduct of a Clinical Trial: An Industry Perspective
Reviews on Recent Clinical Trials Defining Primary and Secondary Progenitor Disorders in the Brain: Proteomic Approaches for Analysis of Neural Progenitor Cells
Current Pharmaceutical Biotechnology RAAS Inhibition and Renal Protection
Current Pharmaceutical Design Increased Pulmonary Heme Oxygenase-1 and δ-Aminolevulinate Synthase Expression in Monocrotaline-Induced Pulmonary Hypertension
Current Neurovascular Research The Metabotropic Glutamate Receptors: Structure, Activation Mechanism and Pharmacology
Current Drug Targets - CNS & Neurological Disorders Juvenile Scleroderma-What has Changed in the Meantime?
Current Rheumatology Reviews Non-coding RNAs and Hypertension–Unveiling Unexpected Mechanisms of Hypertension by the Dark Matter of the Genome
Current Hypertension Reviews Evolving Strategies in Manipulating VEGF/VEGFR Signaling for the Promotion of Angiogenesis in Ischemic Muscle
Current Pharmaceutical Design Elucidation of the Mechanisms and Molecular Targets of Qishen Yiqi Formula for the Treatment of Pulmonary Arterial Hypertension using a Bioinformatics/Network Topology-based Strategy
Combinatorial Chemistry & High Throughput Screening Essential Fatty Acids - A Review
Current Pharmaceutical Biotechnology A Systematic Review of Grand Multiparity
Current Women`s Health Reviews The Role of Trimetazidine After Acute Myocardial Infarction
Current Vascular Pharmacology Cardiovascular Diseases and the Nitric Oxide Pathway
Current Vascular Pharmacology <i>In-situ</i> Intestinal Absorption and Pharmacokinetic Investigations of Carvedilol Loaded Supersaturated Self-emulsifying Drug System
Pharmaceutical Nanotechnology Long Non-coding RNAs in Heart Failure: A Deep Belief Network Based Cluster Analysis
Current Bioinformatics Iron Supplementation Therapy in End-Stage Renal Disease Patients on Maintenance Hemodialysis
Cardiovascular & Hematological Disorders-Drug Targets Advances in Catheter Ablation: Atrial Fibrillation Ablation in Patients With Mitral Mechanical Prosthetic Valve
Current Cardiology Reviews Blood microRNA-15a Correlates with IL-6, IGF-1 and Acute Cerebral Ischemia
Current Neurovascular Research PPARs in Neurodegenerative and Neuroinflammatory Pathways
Current Alzheimer Research Molecular Genetics of Abdominal Aortic Aneurysm: Therapeutic Implications
Current Pharmacogenomics and Personalized Medicine